Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features

Open access
Navarro, Alba, Clot, Guillem, Royo, Cristina, Jares, Pedro, Hadzidimitriou, Anastasia, Agathangelidis, Andreas, Bikos, Vasilis, Darzentas, Nikos, Papadaki, Theodora, Salaverria, Itziar, Pinyol, Magda, Puig, Xavier, Palomero, Jara, Vegliante, Maria Carmela, Amador, Virgina, Martinez-Trillos, Alejandra, Stefancikova, Lenka, Wiestner, Adrian, Wilson, Wyndham, Pott, Christiane, Calasanz, Maria Jose, Trim, Nicola, Erber, Wendy, Sander, Birgitta, Ott, German, Rosenwald, Andreas, Colomer, Dolors, Giné, Eva, Siebert, Reiner, Lopez-Guillermo, Armando, Stamatopoulos, Kostas, Beà, Sílvia, Campo, Elías·2012·Cancer Research

Abstract

Mantle cell lymphoma (MCL) is a heterogeneous disease with most patients following an aggressive clinical course, whereas others having an indolent behavior. We conducted an integrative and multidisciplinary analysis of 177 MCL to determine whether the immunogenetic features of the clonotypic B-cell receptors (BcR) may identify different subsets of tumors. Truly unmutated (100% identity) IGHV genes were found in 24% cases, 40% were minimally/borderline mutated (99.9%–97%), 19% significantly mutated (96.9%–95%), and 17% hypermutated (<95%). Tumors with high or low mutational load used different IGHV genes, and their gene expression profiles were also different for several gene pathways. A gene set enrichment analysis showed that MCL with high and low IGHV mutations were enriched in memory and naive B-cell signatures, respectively. Furthermore, the highly mutated tumors had less genomic complexity, were preferentially SOX11-negative, and showed more frequent nonnodal disease. The best cut-off of germline identity of IGHV genes to predict survival was 97%. Patients with high and low mutational load had significant different outcome with 5-year overall survival (OS) of 59% and 40%, respectively (P = 0.004). Nodal presentation and SOX11 expression also predicted for poor OS. In a multivariate analysis, IGHV gene status and SOX11 expression were independent risk factors. In conclusion, these observations suggest the idea that MCL with mutated IGHV, SOX11-negativity, and nonnodal presentation correspond to a subtype of the disease with more indolent behavior. Cancer Res; 72(20); 5307–16. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-12-1615

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 256

Metadata

Authors
Navarro, A., Clot, G., Royo, C., Jares, P., Hadzidimitriou, A., Agathangelidis, A., Bikos, V., Darzentas, N., Papadaki, T., Salaverria, I., Pinyol, M., Puig, X., Palomero, J., Vegliante, M. C., Amador, V., Martinez-Trillos, A., Stefancikova, L., Wiestner, A., Wilson, W., Pott, C., Calasanz, M. J., Trim, N., Erber, W., Sander, B., Ott, G., Rosenwald, A., Colomer, D., Giné, E., Siebert, R., Lopez-Guillermo, A., Stamatopoulos, K., Beà, S., & Campo, E.
Venue
Cancer Research
Published
2012-10-14
Volume
72
Issue
20
Pages
5307-5316
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2096672814
Cited by
256
References
32
FWCI
14.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-1615
The paper
Navarro, A., Clot, G., Royo, C., Jares, P., Hadzidimitriou, A., Agathangelidis, A., Bikos, V., Darzentas, N., Papadaki, T., Salaverria, I., Pinyol, M., Puig, X., Palomero, J., Vegliante, M. C., Amador, V., Martinez-Trillos, A., Stefancikova, L., Wiestner, A., Wilson, W., . . . Campo, E. (2012). Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-1615

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.